Cutler Group’s Neuronetics STIM Stock Holding History

Cutler Group’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-600	Closed	-$1K	–	6328
2021 Q2	$1K	Buy	+600	New	+$8.29K	﹤0.01%	5425

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Cutler Group's STIM Position: Q4 2021 in Review

Cutler Group sold out of Neuronetics (STIM) in Q4 2021, closing a stake of 400 shares — an estimated $2K sold.

Cutler Group first reported a position in STIM in Q2 2021 and held it in 2 quarters. The position peaked at $6K in Q2 2021. 80 funds tracked by Wall St. Rank hold STIM as of Q4 2021.

Cutler Group reported no remaining Neuronetics position as of Q4 2021 after selling out during the quarter.
Cutler Group sold 400 Neuronetics shares in Q4 2021, an estimated $2K.
Cutler Group first reported a position in Neuronetics in Q2 2021 and held it in 2 quarters.
Cutler Group's Neuronetics position peaked at $6K in Q2 2021.
80 funds tracked by Wall St. Rank held Neuronetics as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.